These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19846)

  • 21. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acquired inhibitors (autoantibodies) to coagulation factors in non-hemophilic patients].
    Okamura T; Tsuda H
    Rinsho Ketsueki; 1993 May; 34(5):583-7. PubMed ID: 7686235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE; Carton CL; Hougie C
    J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibitor hemophilia A--diagnostic and therapeutic significance of controlled substitutions with factor VIII].
    Weippert M; Anders O; Schmidt M; Roewer J
    Beitr Infusionsther; 1990; 26():174-8. PubMed ID: 1703823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
    Poon MC; Wine AC; Ratnoff OD; Bernier GM
    Blood; 1975 Sep; 46(3):409-16. PubMed ID: 50101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.
    Kazatchkine MD; Sultan Y; Burton-Kee EJ; Mowbray JF
    Clin Exp Immunol; 1980 Feb; 39(2):315-20. PubMed ID: 6771074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transient inhibitors developed in two cases of hemophilia A].
    Fujiwara F; Kanoh G; Ogawa H; Takaya K; Hibi S; Shima M; Yoshioka A; Imashuku S
    Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP; Gaillandre A; Frommel D
    Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicohaematological profile of two cases of inhibitors to factor VIII.
    Shanthala Devi AM; Srikrishna A; Sitalaksmi S; Damodar P
    Indian J Pathol Microbiol; 2001 Jul; 44(3):365-6. PubMed ID: 12024937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative effects of the reaction between factor VIII and factor VIII inhibitors.
    McMillan CW; Elston RC
    Thromb Diath Haemorrh; 1971 Aug; 26(1):124-34. PubMed ID: 5112370
    [No Abstract]   [Full Text] [Related]  

  • 38. An acquired inhibitor to factor VIIIC in a non-hemophiliac: twenty years of observation and characterization.
    Coots MC; Glueck HI
    Am J Hematol; 1987 Apr; 24(4):415-24. PubMed ID: 3105306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Elderly non-hemophiliac patient with factor VIII inhibitor presenting various type hemorrhages].
    Sadakata H; Yatabe H; Shinozaki T; Narahara N; Naruse T; Tsuchiya J
    Nihon Ronen Igakkai Zasshi; 1995 Jan; 32(1):47-50. PubMed ID: 7739144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological analysis of acquired factor VIII inhibitor in a case with immunologic disorder.
    Okamura T; Yamauchi Y; Fukuda T; Suehiro K; Murakawa M; Shibuya T; Nagasawa K; Harada M; Niho Y
    Acta Haematol; 1991; 85(3):153-5. PubMed ID: 1710410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.